Everolimus versus sunitinib prospective evaluation in metastatic non-clear cell renal cell carcinoma (The ESPN Trial): A multicenter randomized phase 2 trial.-Reference-Cited by-同舟云学术

Everolimus versus sunitinib prospective evaluation in metastatic non-clear cell renal cell carcinoma (The ESPN Trial): A multicenter randomized phase 2 trial.

Published:2014-05-20 Issue:15_suppl Volume:32 Page:4505-4505
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Tannir Nizar M.¹,Jonasch Eric¹,Altinmakas Emre¹,Ng Chaan S.¹,Qiao Wei²,Tamboli Pheroze¹,Rao Priya¹,McDermott David F.³,Wood Christopher G.¹,Choueiri Toni K.⁴

Affiliation:

1. The University of Texas MD Anderson Cancer Center, Houston, TX

2. Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX

3. Beth Israel Deaconess Medical Center, Boston, MA

4. Dana-Farber Cancer Institute, Boston, MA

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/jco.2014.32.15_suppl.4505

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Temsirolimus in Asian Metastatic/Recurrent Non-clear Cell Renal Carcinoma;Cancer Research and Treatment;2019-10-15

2. Cabozantinib for the treatment of patients with metastatic non-clear cell renal cell carcinoma: A retrospective analysis;European Journal of Cancer;2018-11

3. TFE/Translocation Morphology Renal Cell Carcinoma;Rare Kidney Tumors;2018-09-30

4. Axitinib, cabozantinib, everolimus, nivolumab, sunitinib and best supportive care in previously treated renal cell carcinoma: a systematic review and economic evaluation;Health Technology Assessment;2018-01

5. Characterization of Clinical Cases of Advanced Papillary Renal Cell Carcinoma via Comprehensive Genomic Profiling;European Urology;2018-01